156 related articles for article (PubMed ID: 33798683)
1. Integration of transcriptomics and metabolomics reveals anlotinib-induced cytotoxicity in colon cancer cells.
Jia Z; Zhang Z; Tian Q; Wu H; Xie Y; Li A; Zhang H; Yang Z; Zhang X
Gene; 2021 Jun; 786():145625. PubMed ID: 33798683
[TBL] [Abstract][Full Text] [Related]
2. Transcriptome profiling analysis reveals that ATP6V0E2 is involved in the lysosomal activation by anlotinib.
Sun X; Shu Y; Yan P; Huang H; Gao R; Xu M; Lu L; Tian J; Huang D; Zhang J
Cell Death Dis; 2020 Aug; 11(8):702. PubMed ID: 32839434
[TBL] [Abstract][Full Text] [Related]
3. Integrative omics analysis of p53-dependent regulation of metabolism.
Huang J; Long Z; Lin W; Liao X; Xie Y; Liu L; Ma W
FEBS Lett; 2018 Feb; 592(3):380-393. PubMed ID: 29323703
[TBL] [Abstract][Full Text] [Related]
4. TOP2A and CENPF are synergistic master regulators activated in cervical cancer.
Yu B; Chen L; Zhang W; Li Y; Zhang Y; Gao Y; Teng X; Zou L; Wang Q; Jia H; Liu X; Zheng H; Hou P; Yu H; Sun Y; Zhang Z; Zhang P; Zhang L
BMC Med Genomics; 2020 Oct; 13(1):145. PubMed ID: 33023625
[TBL] [Abstract][Full Text] [Related]
5. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
[TBL] [Abstract][Full Text] [Related]
6. Proliferation and invasion of colon cancer cells are suppressed by knockdown of TOP2A.
Zhang R; Xu J; Zhao J; Bai JH
J Cell Biochem; 2018 Sep; 119(9):7256-7263. PubMed ID: 29761838
[TBL] [Abstract][Full Text] [Related]
7. Transcriptomic analysis and identification of prognostic biomarkers in cholangiocarcinoma.
Li H; Long J; Xie F; Kang K; Shi Y; Xu W; Wu X; Lin J; Xu H; Du S; Xu Y; Zhao H; Zheng Y; Gu J
Oncol Rep; 2019 Nov; 42(5):1833-1842. PubMed ID: 31545466
[TBL] [Abstract][Full Text] [Related]
8. Tissue-based metabolomics reveals metabolic signatures and major metabolic pathways of gastric cancer with help of transcriptomic data from TCGA.
Wang Y; Chen W; Li K; Wu G; Zhang W; Ma P; Feng S
Biosci Rep; 2021 Oct; 41(10):. PubMed ID: 34549263
[TBL] [Abstract][Full Text] [Related]
9. Integrated transcriptomic and metabolomic analyses to characterize the anti-cancer effects of (-)-epigallocatechin-3-gallate in human colon cancer cells.
Zhang Z; Zhang S; Yang J; Yi P; Xu P; Yi M; Peng W
Toxicol Appl Pharmacol; 2020 Aug; 401():115100. PubMed ID: 32512070
[TBL] [Abstract][Full Text] [Related]
10. Metabolomics and transcriptomics profiles reveal the dysregulation of the tricarboxylic acid cycle and related mechanisms in prostate cancer.
Shao Y; Ye G; Ren S; Piao HL; Zhao X; Lu X; Wang F; Ma W; Li J; Yin P; Xia T; Xu C; Yu JJ; Sun Y; Xu G
Int J Cancer; 2018 Jul; 143(2):396-407. PubMed ID: 29441565
[TBL] [Abstract][Full Text] [Related]
11. SMC3 may play an important role in atopic asthma development.
Cheng Q; Huang W; Chen N; Shang Y; Zhang H
Clin Respir J; 2016 Jul; 10(4):469-76. PubMed ID: 25515564
[TBL] [Abstract][Full Text] [Related]
12. Identification of Transcriptional Markers and microRNA-mRNA Regulatory Networks in Colon Cancer by Integrative Analysis of mRNA and microRNA Expression Profiles in Colon Tumor Stroma.
Uddin MN; Li M; Wang X
Cells; 2019 Sep; 8(9):. PubMed ID: 31500382
[TBL] [Abstract][Full Text] [Related]
13. The aspartate metabolism pathway is differentiable in human hepatocellular carcinoma: transcriptomics and (13) C-isotope based metabolomics.
Darpolor MM; Basu SS; Worth A; Nelson DS; Clarke-Katzenberg RH; Glickson JD; Kaplan DE; Blair IA
NMR Biomed; 2014 Apr; 27(4):381-9. PubMed ID: 24497316
[TBL] [Abstract][Full Text] [Related]
14. Global gene expression profiling of cells overexpressing SMC3.
Ghiselli G; Liu CG
Mol Cancer; 2005 Sep; 4():34. PubMed ID: 16156898
[TBL] [Abstract][Full Text] [Related]
15. Spica Prunellae Extract Enhances Fluorouracil Sensitivity of 5-Fluorouracil-Resistant Human Colon Carcinoma HCT-8/5-FU Cells via TOP2
Fang Y; Yang C; Zhang L; Wei L; Lin J; Zhao J; Peng J
Biomed Res Int; 2019; 2019():5953619. PubMed ID: 31662984
[TBL] [Abstract][Full Text] [Related]
16. Metabolomics study on the antitumor effect of marine natural compound flexibilide in HCT-116 colon cancer cell line.
Gao D; Wang Y; Xie W; Yang T; Jiang Y; Guo Y; Guan J; Liu H
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Mar; 1014():17-23. PubMed ID: 26859520
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous quantitative determination of arachidonic acid and cascade metabolites in rat serum by UPLC-MS/MS: application for longitudinal metabolomics of anlotinib.
Du P; Hu T; An Z; Li P; Liu L
Analyst; 2020 Jul; 145(14):4972-4981. PubMed ID: 32515434
[TBL] [Abstract][Full Text] [Related]
18. Integration of Metabolomics and Transcriptomics Reveals Major Metabolic Pathways and Potential Biomarker Involved in Prostate Cancer.
Ren S; Shao Y; Zhao X; Hong CS; Wang F; Lu X; Li J; Ye G; Yan M; Zhuang Z; Xu C; Xu G; Sun Y
Mol Cell Proteomics; 2016 Jan; 15(1):154-63. PubMed ID: 26545398
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and disposition of anlotinib, an oral tyrosine kinase inhibitor, in experimental animal species.
Zhong CC; Chen F; Yang JL; Jia WW; Li L; Cheng C; Du FF; Zhang SP; Xie CY; Zhang NT; Olaleye OE; Wang FQ; Xu F; Lou LG; Chen DY; Niu W; Li C
Acta Pharmacol Sin; 2018 Jun; 39(6):1048-1063. PubMed ID: 29620050
[TBL] [Abstract][Full Text] [Related]
20. UHPLC-HRMS-based metabolomic and lipidomic characterization of glioma cells in response to anlotinib.
Shi Y; Li Z; Du Q; Li W; Liu J; Jia Q; Xue L; Zhang X; Sun Z
Sci Rep; 2023 May; 13(1):8044. PubMed ID: 37198251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
